We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
SGLT2 inhibitors - moving on with the evidence.
- Authors
Morris, David
- Abstract
The evidence base on the benefits and risks of using sodium-glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycaemia has grown in recent years, with data showing potential cardiovascular and renal benefits, along with safety concerns that warrant cautious use and monitoring in certain users. This article reviews the benefits and difficulties associated with the use of SGLT2 inhibitors in people with type 2 diabetes and, potentially, type 1 diabetes.
- Publication
Journal of Diabetes Nursing, 2019, Vol 23, Issue 4, p1
- ISSN
1368-1109
- Publication type
Academic Journal